VCM
CGON icon

Voleon Capital Management’s CG Oncology CGON Stock Holding History

Voleon Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$871K Buy
12,874
+3,175
+33% +$180K 0.02% 461
2025
Q4 		$403K Sell
9,699
-473
-5% -$19.6K 0.01% 619
2025
Q3 		$410K Buy
+10,172
New +$296K 0.01% 639

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Voleon Capital Management's CGON Position: Q1 2026 in Review

Voleon Capital Management increased its CG Oncology (CGON) stake by 33% in Q1 2026, buying an estimated $180K and bringing the position to 12,874 shares worth $871K. The position accounts for 0.02% of the portfolio, ranked #461.

Voleon Capital Management first reported a position in CGON in Q3 2025 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Voleon Capital Management held 12,874 shares of CG Oncology worth $871K as of Q1 2026.
  • Voleon Capital Management bought 3,175 CG Oncology shares in Q1 2026, an estimated $180K.
  • CG Oncology made up 0.02% of Voleon Capital Management's portfolio in Q1 2026, its #461 holding.
  • Voleon Capital Management first reported a position in CG Oncology in Q3 2025 and has held it in 3 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.